| Literature DB >> 31579403 |
Youshui Gao1, Junjie Gao2, Hengyuan Li3, Dajiang Du2, Dongxu Jin2, Minghao Zheng4, Changqing Zhang5.
Abstract
It is a great challenge to cure symptomatic lesions and considerable defects of hyaline cartilage due to its complex structure and poor self-repair capacity. If left untreated, unmatured degeneration will cause significant complications. Surgical intervention to repair cartilage may prevent progressive joint degeneration. A series of surgical techniques, including biological augmentation, microfracture and bone marrow stimulation, autologous chondrocyte implantation (ACI), and allogenic and autogenic chondral/osteochondral transplantation, have been used for various indications. However, the limited repairing capacity and the potential pitfalls of these techniques cannot be ignored. Increasing evidence has shown promising outcomes from ACI and cartilage transplantation. Nevertheless, the morbidity of autologous donor sites and limited resource of allogeneic bone have considerably restricted the wide application of these surgical techniques. Costal cartilage, which preserves permanent chondrocytes and the natural osteochondral junction, is an ideal candidate for the restoration of cartilage defects. Several in vitro and in vivo studies have shown good performance of costal cartilage transplantation. Although costal cartilage is a classic donor in plastic and cosmetic surgery, it is rarely used in skeletal cartilage restoration. In this review, we introduce the fundamental properties of costal cartilage and summarize costa-derived chondrocyte implantation and costal chondral/osteochondral transplantation. We will also discuss the pitfalls and pearls of costal cartilage transplantation. Costal chondral/osteochondral transplantation and costa-based chondrocytotherapy might be up-and-coming surgical techniques for recalcitrant cartilage lesions.Entities:
Keywords: cartilage defect; chondrocyte; costal cartilage; cytotherapy; tissue engineering
Year: 2019 PMID: 31579403 PMCID: PMC6759717 DOI: 10.1177/1759720X19877131
Source DB: PubMed Journal: Ther Adv Musculoskelet Dis ISSN: 1759-720X Impact factor: 5.346
Figure 1.Schematic of costal chondral/osteochondral transplantation and costa-derived chondrocytotherapy.
The costal junction may indicate a deep osteochondral lesion, and the costal cartilage may be used for full-thickness cartilage defects. Alternatively, costal cartilage may be cut into small pieces, and digested and expanded in vitro to obtain sufficient chondrocytes. The costa-derived chondrocytes are functional seed cells to cure cartilage defects and growth plate injury.
Figure 2.Multilayered structure of the cartilage from the femoral head.
Chondrocytes in different stages of maturation are buried in the extracellular matrix with varied ossification (Goldner Trichome staining).